PharPoint, a contract research organization, has created a fully-dedicated consulting division. Led by Chief Scientific Officer Dr. Jennifer A. Elder, the division will serve small pharmaceutical and biotechnology companies that cannot staff in-house teams to manage functions like biostatistics or regulatory compliance. PharPoint’s experts work with clientele to develop personalized plans to, for example, navigate Food and Drug Administration trials intentionally, avoiding wasted time and effort. Informed and experienced consultants can develop risk/benefit profiles for proposed products, which include costs of testing and timelines for moving through the FDA approval process. They can also help clients analyze data and otherwise prepare reports in accordance with FDA standards. Other services include pitching products for inventors who prefer the thrill of discovery to honing their marketing skills, and introducing products in the international market.